基本信息:
- 专利标题: STABILIZATION AND/OR ISOLATION OF NUCLEIC ACID
- 申请号:JP2000045524 申请日:2000-02-23
- 公开(公告)号:JP2000342259A 公开(公告)日:2000-12-12
- 发明人: ERBACHER CHRISTOPH , BASTIAN HELGE , WYRICH RALF , OELMUELLER UWE , MANZ THOMAS
- 申请人: QIAGEN GMBH
- 专利权人: QIAGEN GMBH
- 当前专利权人: QIAGEN GMBH
- 优先权: EP99103457 1999-02-23
- 主分类号: G01N33/50
- IPC分类号: G01N33/50 ; A61K31/14 ; A61K31/495 ; A61K31/7088 ; C07C211/63 ; C07D295/02 ; C07H1/00 ; C07H1/06 ; C07H21/02 ; C07H21/04 ; C12N15/09 ; C12N15/10 ; C12Q1/00 ; C12Q1/68
摘要:
PROBLEM TO BE SOLVED: To obtain a medicine composition, a diagnosis composition and a study composition by bringing a specific cationic compound into contact with a biological sample, stabilizing a nucleic acid from the biological sample and isolating the nucleic acid. SOLUTION: A base bonded to a strong and/or weak inorganic and/or organic acid is used as an anion. A cationic compound in which a substance comprising a cationic compound and an anion is totally neutral and which is one or more cationic compounds of the formula [X is N or P; k is 1-24; Bk is a (substitute) aliphatic alkanediyl crosslinking, substituted phenyl, naphthyl or biphenyl crosslinking; R1, R2 and RBk are H, a (substitute) 1-6C alkyl, phenyl or the like; RA, RBk and RC are each H, a (substitute) 1-21C alkyl, a 1-21C alkenyl or the like] such as ethanediyl-1,2-bis(dimethyldecylammonium bromide) is brought into contact with a biological sample such as clinical sample, for example, blood, etc., to stabilize and/or isolate a nucleic acid from the biological sample.
公开/授权文献:
- JP4809967B2 Stabilization of nucleic acid and / or isolation of the way 公开/授权日:2011-11-09